NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
Clinical Trials
9 trialsNCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT02361125 2022-01-04
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00096356 2021-09-29
CoQ10
Wake Forest University Health Sciences
Phase 1 Completed
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT01164956 2019-04-26
Methylphenidate for Cancer-Related Fatigue
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT02106871 2017-10-27
PCC
The University of Texas Medical Branch, Galveston
Phase 1 Withdrawn
NCT01867723 2015-10-28
Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet
Oslo University Hospital
Phase 1 Completed
NCT00294203 2014-04-15
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
University of Florida
Phase 1 Completed